Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action.
Increasing preclinical and clinical evidence underscores the strong and rapid antidepressant properties of the glutamate-modulating NMDA receptor antagonist ketamine. Targeting the glutamatergic system might thus provide a novel molecular strategy for antidepressant treatment. Since glutamate is the...
Main Authors: | Milan Scheidegger, Martin Walter, Mick Lehmann, Coraline Metzger, Simone Grimm, Heinz Boeker, Peter Boesiger, Anke Henning, Erich Seifritz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3461985?pdf=render |
Similar Items
-
Differential Alterations in Resting State Functional Connectivity Associated with Depressive Symptoms and Early Life Adversity
by: Eleonora Fadel, et al.
Published: (2021-05-01) -
Ketamine: stimulating antidepressant treatment?
by: Malhi, G, et al.
Published: (2016) -
Ketamine: A New Antidepressant?
by: Feride Karacaer
Published: (2015-03-01) -
Ketamine: stimulating antidepressant treatment?
by: Gin S. Malhi, et al.
Published: (2016-05-01) -
Immunoregulation and antidepressant effect of ketamine
by: Zhang Nan, et al.
Published: (2021-05-01)